Sudden Death in Young Patients With Hypertrophic Cardiomyopathy May be Prevented by ICDs, Minneapolis Heart Institute Study
Published: Nov 07, 2012
A multicenter registry has demonstrated that the use of implantable cardioverter-defibrillators (ICDs) to combat sudden cardiac death in high-risk pediatric patients suffering from hypertrophic cardiomyopathy (HCM). The study was presented at the 2012 Scientific Sessions of the American Heart Association (AHA) in Los Angeles. While the study found that the rate of possible device complications adds a level of complexity to this age group, it also demonstrated that life-saving ICD interventions were common in younger patients when terminating irregular heart rhythms, called ventricular tachyarrhythmias or fibrillation.